bluebird bio, a leader in the development of potentially transformative one-time gene therapies for severe genetic diseases, announced today that Nick Leschly, chief bluebird, is scheduled to present at the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at 9:30 AM PST at the Westin St. Francis Hotel in San Francisco.
